Site Map

Delta-ALA urine test

Delta-aminolevulinic acid

Delta-ALA is a protein (amino acid) produced by the liver. A test can be done to measure the amount of this substance in the urine.

Images

I Would Like to Learn About:

How the Test is Performed

Your health care provider will ask you to collect your urine at home over 24 hours. This is called a 24-hour urine sample. Your provider will tell you how to do this. Follow instructions exactly.

How to Prepare for the Test

Your provider may tell you to temporarily stop taking any medicines that can affect test results. Be sure to tell your provider about all the medicines you take. These include:

• Penicillin (an antibiotic)
• Barbiturates (medicines to treat anxiety)
• Birth control pills
• Griseofulvin (medicine to treat fungal infections)

How the Test will Feel

The test involves only normal urination. There is no discomfort.

Why the Test is Performed

This test looks for an increased level of delta-ALA. It may be used to help diagnose a blood disorder called porphyria.

Normal Results

Normal value range for adults is 1.0 to 7.0 mg (7.6 to 53.3 mol/L) over 24 hours.

Normal value ranges may vary slightly from one lab to another. Some labs use different measurements or test different samples. Talk to your provider about the meaning of your specific test results.

What Abnormal Results Mean

An increased level of urinary delta-ALA may indicate:

• Lead poisoning
• Porphyria (several types)

 A decreased level may occur with chronic (long-term) liver disease.

Risks

There are no risks with this test.

Related Information

Liver disease

References

Fuller SJ, Wiley JS. Heme biosynthesis and its disorders: porphyrias and sideroblastic anemias. In: Hoffman R, Benz EJ, Silberstein LE, et al, eds. Hematology: Basic Principles and Practice. 8th ed. Philadelphia, PA: Elsevier; 2023:chap 39.

Squires JE, Balistreri WF. Other inherited metabolic disorders of the liver. In: Feldman M, Friedman LS, Brandt LJ, eds. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. 11th ed. Philadelphia, PA: Elsevier; 2021:chap 77.

BACK TO TOP

Review Date: 2/2/2023  

Reviewed By: Mark Levin, MD, Hematologist and Oncologist, Monsey, NY. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

Health Content Provider 06/01/2025

A.D.A.M., Inc. is accredited by URAC, for Health Content Provider (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics. This site complied with the HONcode standard for trustworthy health information from 1995 to 2022, after which HON (Health On the Net, a not-for-profit organization that promoted transparent and reliable health information online) was discontinued.

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- 2024 A.D.A.M., a business unit of Ebix, Inc. Any duplication or distribution of the information contained herein is strictly prohibited.